Please upgrade your browser.
Carol London, from Kings Cross, is running in this years marathon in memory of her 12-year-old daughter Saffron, who died in 2007 after developing a rare kidney cancer.
In How to Fix Medicare: Let's Pay Patients, Not Physicians, health economist Roger Feldman argues that a radical shift in Medicare policy is not only possible but imperative. Under Feldman's "medical indemnity" proposal, Medicare would pay each patient a fixed amount of money, reserving larger subsidies for sicker people. Patients, in turn, would select their own medical services from providers who would set their own competitive rates.
A type of drug designed to stunt tumour growth has actually been found to fuel cancer if given at too low a dose.
In vitro testing of darinaparsin using the National Cancer Institute's human cancer cell panel detected activity against a series of tumor cell lines including lung, colon, brain, melanoma, ovarian, and kidney cancer.
Drugmakers have to wait for patients to trickle through other medications and many patients will be sopped up by the other drugs. It's better used as a way to get your foot in the door, as Novartis (NYSE: NVS) is trying to do with Afinitor, its kidney cancer treatment for patients who have failed current treatments.
The company's lead product, AV-951, a potential best-in-class triple VEGF receptor inhibitor, is in a Phase 2 clinical trial in more than 270 patients with metastatic renal cell cancer and is expected to enter Phase 3 development in 2009.
Alcohol intake was associated with decreased risks of certain cancers, including thyroid cancer, non-Hodgkin lymphoma, and renal cell carcinoma (the main type of kidney cancer).
The first U.S. kidney cancer vaccine trial is now underway at Columbia University Medical Center and NewYork-Presbyterian Hospital/Columbia. While the potential for vaccines to treat solid tumors has been recognized for more than a decade, this trial is pioneering the use of tumor immunotherapy -- boosting the bodys natural immune system -- as a way to fight cancer.
Clifts husband died quietly at home from kidney cancer at 64, one day before the much more public death of Terri Schiavo. Juxtaposing these narratives, one intimate and one bitterly political, Clift, a contributing editor for Newsweek, underscores the need to talk about death.
If we had evidence-based public policy, the policy wonks would be singing hallelujahs about consumer-directed health. But don't hold your breath. That would get in the way of the real agenda, which has nothing to do with what works and what fails. It is all about who is in control. Period.
|Powered by NeonCRM|